New CEO for PIQUR

Please login or
register
24.06.2019
Melanie Rolli

The Board of Directors of PIQUR Therapeutics AG appointed Melanie Rolli as Chief Executive Officer. In her previous role as COO she led the refocusing of the development program of PIQUR’s lead compound and also helped to significantly reduce the operating expenses.

Melanie Rolli joined PIQUR in 2017 as Chief Medical Officer and took on additional responsibilities as Chief Operating Officer in 2018. Prior to joining PIQUR she worked for Novartis Pharma, where she held various positions with increasing responsibilities over 14 years, most recently as Global Head Medical Safety. Richard Laube will remain serving as Chairman of PIQUR’s Board of Directors.

Richard Laube highlights the outstanding efforts of Dr. Rolli in driving PIQUR’s business. “Under Dr. Rolli’s leadership as Chief Operating Officer, PIQUR has refocused the bimiralisib oral cancer clinical development program towards a promising individualised therapy treating patients with head and neck cancer harboring specific mutations. Furthermore, she has been instrumental in accelerating the development of the bimiralisib’s topical application with the completion of the preclinical program, and shortly entering Phase 1 human trials to treat cutaneous T-cell lymphoma. In addition, Dr. Rolli has worked to significantly reduce PIQUR’s operating expenses while simultaneously improving the quality and motivation of PIQUR’s associates. The company is on track with all of its strategic initiatives,” said Richard Laube.

PIQUR seeks to develop and market next generation medications for the treatment of cancer. Its lead compound PQR309 / bimiralisib is a novel, potent small molecule. In May 2019 the recruitment started for a Phase II study evaluating the efficacy and safety of bimiralisib in patients with recurrent or metastatic head and neck squamous cell carcinomas (HNSCC) harboring NOTCH1 loss of function (LOF) mutations.

(Press release)

0Comments

More news about

PIQUR Therapeutics AG

Company profiles on startup.ch

PIQUR Therapeutics AG

rss